Octreotide LAR的意思|示意
Octreotide守护神
Octreotide LAR的网络常见释义
长效奥曲肽 （2）兰瑞肽（Lanreotide）和长效奥曲肽（Octreotide LAR）：兰瑞肽，是一种新型长效生长抑素类似物，每2周肌注30mg；奥曲肽LAR，每4周肌注1次。
奥曲肽长效制剂 ②奥曲肽长效制剂：奥曲肽长效制剂(Octreotide LAR)是采用生物降解多聚 体技术使奥曲肽缓慢释放而获得的。
Octreotide LAR相关例句
Overall safety of the octreotide implant and octreotide lar were similar.
奥曲肽植入物的整体安全性与奥曲肽类似物相似。
Randomization was in a 3:1 ratio to either 6-month octreotide implant or monthly octreotide LAR injections.
按3：1比例随机分到6个月奥曲肽植入或每月奥曲肽类似物注射。
Diarrhea and headache were more frequent with the implant, while cholecystitis and hypertension were more frequent with octreotide LAR.
奥曲肽植入物常见的不良反应为腹泻和头痛，而奥曲肽类似物更常见的为胆囊炎和高血压。
Results: After 24 weeks, the success rate of the implant for maintenance of IGF-1 and GH levels was 86% (95% CI: 80.3%) compared to 84% (95% CI: 73.8%) for octreotide LAR.
结果：24周后，与奥曲肽类似物维持igf—1和GH水平的成功率为84% (95% CI： 73.8%)相比，奥曲肽植入物的成功率为86% (95% CI： 80.3%)。